PATENT CLAIM ANALYSIS

Application Number: 15962507
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "250100"]

Abstract:
An injectable immunogenic composition comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of  Neisseria meningitidis , wherein said capsular saccharides are conjugated to carrier protein(s) and/or are oligosaccharides, and wherein (i) the composition comprises <50 μg meningococcal saccharide per dose, and/or (ii) the composition further comprises an antigen from one or more of: (a) serogroup B  N.meningitidis ; (b)  Haemophilus influenzae  type B; and/or (c)  Streptococcus pneumoniae . Saccharide antigens in the compositions are generally conjugated to a carrier.

Claim (Index 31):
The composition of  claim 28 , further comprising an antigen that protects against  Haemophilus  influenza type B.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.53623
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10543455', '15240385', '12321418', '10514207', '12321417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8302018736979404
- 35 USC 102 Novelty (BERT): 0.5978175789061865
- Combined Prediction Score: 0.8069634442187651
- Mean Citation Score: 596.0288600000001
- Max Citation Score: 650.1676
- Similarity Product: 438.73536908044815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test